(Associate) Director, Science2Medicines iNNvest
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Do you want to contribute to the corporate investment portfolio and strategy within Research & Early Development (R&ED), with the aim of impacting our pipeline? Do you have a scientific background and experience with venture capital? Apply now to contribute to our investment portfolio, strategy, influence business cases, and advance external innovation within the Global Drug Discovery (GDD) organization. Join us in driving innovation and growth. The position
In this position, you will work closely with internal and external stakeholders to contribute to Novo Nordisk's Minority Investment strategy and activities within R&ED, aiming to impact our pipeline through a portfolio of equity investments (Seed and Series A) within the cardiometabolic space. You will use your expertise to scout for external investment opportunities and build business cases that you will present to senior leadership. You will forge and maintain an external network to ensure that Novo Nordisk R&ED becomes an industry leader and partner in developing relations and interactions with start-ups, biotech, entrepreneurs and especially venture, globally. Some of your main tasks will include: Building business cases, presenting and defending them to Governance Take the lead in coordinating scientific, financial, and legal diligence of investment cases, including collaboration with relevant specialists and senior leaders Contributing to Novo Nordisk's strategy for External Outreach through building and maintaining a relevant external venture capital network to ensure inflow of investment opportunities The level of seniority and responsibilities associated with the role will be dependent on the candidate's qualifications and experience. Qualifications
To be successful in this position, we expect you to have: PhD in a relevant life science discipline such as biology, pharmacology or similar 5+ years of experience with venture capital and/or search & evaluation within the pharma or biotech industry Strong project management skills A scientific background within cardiometabolism is preferred Deep knowledge of the drug development process Extensive personal network in the pharma industry among academia, start-ups and venture On a personal level, you possess a curious mindset, critical thinking, and a proactive work style that allows you to develop strategies aligned with R&ED needs and innovation objectives. You are a diplomatic communicator, possess strong networking skills and can build strong relations with stakeholders at all levels. Moreover, you are analytical and structured. About the department
The department is anchored in Early Innovation, Outreach & Alliances within Global Drug Discovery, Novo Nordisk A/S with a focus on building a portfolio of equity investments within the cardiometabolic space. The Early Innovation, Outreach & Alliances area includes multiple departments that support external innovation, namely Innovation Outreach, Science2Medicines iNNvest, Scientific Integration, R&ED Due Diligence & Alliance Management. We are a fun and informal team, and we respect and value each other’s differences. Importantly, we all take individual responsibility to help deliver value for Novo Nordisk and novel treatment options to the patients we serve. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information, please contact Neil Anderson, Senior Director on +45 3075 9182. Deadline
2 June 2024. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
In this position, you will work closely with internal and external stakeholders to contribute to Novo Nordisk's Minority Investment strategy and activities within R&ED, aiming to impact our pipeline through a portfolio of equity investments (Seed and Series A) within the cardiometabolic space. You will use your expertise to scout for external investment opportunities and build business cases that you will present to senior leadership. You will forge and maintain an external network to ensure that Novo Nordisk R&ED becomes an industry leader and partner in developing relations and interactions with start-ups, biotech, entrepreneurs and especially venture, globally. Some of your main tasks will include:
To be successful in this position, we expect you to have:
The department is anchored in Early Innovation, Outreach & Alliances within Global Drug Discovery, Novo Nordisk A/S with a focus on building a portfolio of equity investments within the cardiometabolic space. The Early Innovation, Outreach & Alliances area includes multiple departments that support external innovation, namely Innovation Outreach, Science2Medicines iNNvest, Scientific Integration, R&ED Due Diligence & Alliance Management. We are a fun and informal team, and we respect and value each other’s differences. Importantly, we all take individual responsibility to help deliver value for Novo Nordisk and novel treatment options to the patients we serve. Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information, please contact Neil Anderson, Senior Director on +45 3075 9182. Deadline
2 June 2024. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 3.5.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
Laborant til Endotoxin Kompetencecenter
Mangler du nye udfordringer og søger en alsidig hverdag med mange forskellige opgaver? Drives du af opgaver der er svære at løse, men som vi løser sammen og hvor alles input er værdsat? Har du lyst..Få mere info- Forretningsudvikler
- Måløv
-
Project Manager
Job Description:Ser du dig selv som en ansvarlig og dedikeret person der elsker at planlægge, organisere samt styre projekter? Så er det måske dig vi mangler til vores Dentsu kontor i København..Få mere info- Forretningsudvikler
- København K
-
Project Manager - Compliance
About usEvery day, we get opportunities to make a positive impact – on our colleagues, partners, customers and society. Together, we’re pioneering the solutions of the future and unlocking the full..Få mere info- Forretningsudvikler
- Søborg
-
Project Manager
Every day, we get opportunities to make a positive impact – on our colleagues, partners, customers, and society. Together, we’re pioneering the solutions of the future and unlocking the full potent..Få mere info- Forretningsudvikler
- Søborg
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 13. november 2024 | 5 |
| 12. november 2024 | 5 |
| 11. november 2024 | 4 |
| 10. november 2024 | 4 |
| 9. november 2024 | 4 |
| 8. november 2024 | 3 |
| 7. november 2024 | 2 |
| 6. november 2024 | 1 |
| 5. november 2024 | 1 |
| 4. november 2024 | 1 |
| 3. november 2024 | 3 |
| 2. november 2024 | 3 |
| 1. november 2024 | 3 |
| 31. oktober 2024 | 4 |
| 30. oktober 2024 | 4 |
| 29. oktober 2024 | 4 |
| 28. oktober 2024 | 4 |
| 27. oktober 2024 | 6 |
| 26. oktober 2024 | 6 |
| 25. oktober 2024 | 7 |
| 24. oktober 2024 | 7 |
| 23. oktober 2024 | 7 |
| 22. oktober 2024 | 8 |
| 21. oktober 2024 | 9 |
| 20. oktober 2024 | 12 |
| 19. oktober 2024 | 12 |
| 18. oktober 2024 | 11 |
| 17. oktober 2024 | 10 |
| 16. oktober 2024 | 10 |
| 15. oktober 2024 | 10 |
| 14. oktober 2024 | 10 |